Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlpha Real Regulatory News (ARTL)

  • There is currently no data for ARTL

Replacement ART Notes Significant Uplift in IMPT

5 Apr 2017 15:48

RNS Number : 7050B
Alpha Real Trust Limited
05 April 2017
 

5 April 2017

REPLACEMENT ANNOUNCEMENT - ALPHA REAL TRUST LIMITED NOTES SIGNIFICANT UPLIFT IN IMPT VALUE

The Board of Alpha Real Trust Limited ("Alpha Real Trust") notes the announcement by Industrial Multi Property Trust plc ("IMPT") on 4 April 2017 regarding the revaluation of its property portfolio, as carried out by Cushman & Wakefield ("C&W") as at 31 March 2017.

The announcement states that the value of IMPT's property holdings has increased by £1.3 million to £86.2 million, which is equivalent to 15.5p per share.

As previously announced, on 20 February 2017 and 9 March 2017, the Board of Alpha Real Trust believes that the offer by Hansteen Holdings plc ("Hansteen") of 300p per ordinary share for the entire issued ordinary share capital of IMPT grossly undervalues IMPT and has resolved to reject the offer.

In addition to this recent valuation uplift, in Alpha Real Trust's 9 March 2017 announcement reference was made to IMPT's circular of 1 December 2016 in which JLL noted points regarding stamp duty land tax and portfolio premium as points which a purchaser may take into account when negotiating a property acquisition. The Alpha Real Trust board also noted the unused UK tax losses and capital allowances which could represent a deferred tax asset of c.£2.1 million assuming the current 20% UK income tax rate applicable to non-resident landlords (equivalent to 25.0p per IMPT ordinary share), in the event that IMPT has taxable income in future years, against which these tax losses and capital allowances could be offset.

In summary, the 31 December 2016 Adjusted NAV of 307.4p per ordinary share, together with the increased valuation of properties reported by IMPT which equates to 15.5 pence per ordinary share, potential stamp duty land tax savings and available UK tax losses and capital allowances totalling up to £4.1 million (48.8p per IMPT ordinary share),and assuming no other changes in IMPT's adjusted NAV, equates to 371.7p per IMPT ordinary share - which is in excess of the Hansteen offer of 300p per IMPT ordinary share. In addition, whilst JLL comments on a potential portfolio premium, no estimate for this amount was provided.

Whilst acknowledging that the external valuation as at 31 March 2017 is only 3 months since the 31 December 2016 valuation, the increase in value indicates a strengthening in the value of the IMPT property portfolio.

This latest IMPT announcement further supports the board of Alpha Real Trust's belief that the offer by Hansteen grossly undervalues IMPT and its decision to resolve to reject the offer.

 

 

For further information please contact:

Alpha Real Trust Limited

David Jeffreys, Chairman, Alpha Real Trust +44 (0) 1481 231 100

Brad Bauman, Joint Fund Manager, Alpha Real Trust +44 (0) 20 7391 4700

Panmure Gordon, Broker to the Company

Richard Gray / Andrew Potts +44 (0) 20 7886 2500

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBSGDSUSGBGRU
Date   Source Headline
22nd Jan 20252:35 pmRNSTransaction in Own Shares
21st Jan 20252:35 pmRNSShare Buyback
20th Jan 20254:28 pmRNSAcquisition of Crematoria
20th Jan 202510:06 amRNSResult of Tender Offer
20th Dec 202410:18 amRNSResult of Extraordinary General Meeting
17th Dec 20241:53 pmRNSAcquisition of Travelodge hotel in Liverpool, UK
13th Dec 202410:07 amRNSHalf-year Report 2024
6th Dec 20247:00 amRNSDelisting, Tender Offer, New Arts & Notice of EGM
22nd Nov 20247:00 amRNSHalf-year Report
1st Nov 20247:00 amRNSTotal Voting Rights
30th Oct 202411:04 amRNSDirector/PDMR Shareholding
29th Oct 202412:36 pmRNSDirector/PDMR Shareholding
29th Oct 202412:33 pmRNSDirector/PDMR Shareholding
29th Oct 20247:00 amRNSDirector/PDMR Shareholding
22nd Oct 20247:00 amRNSResults of Scrip Dividend Alternative Election
13th Sep 20247:00 amRNSTrading Update and Dividend Announcement
5th Sep 20241:31 pmRNSResult of AGM
1st Aug 20247:00 amRNSTotal Voting Rights
30th Jul 20243:10 pmRNSDirector/PDMR Shareholding
30th Jul 20243:09 pmRNSDirector/PDMR Shareholding
30th Jul 20243:08 pmRNSDirector/PDMR Shareholding
30th Jul 20242:27 pmRNSDirector/PDMR Shareholding
23rd Jul 20247:00 amRNSResults of Scrip Dividend Alternative Election
5th Jul 20249:57 amRNSAnnual Financial Report and Financial Statements
21st Jun 20247:00 amRNSAnnual Results for the year ended 31.03.24
1st May 20247:00 amRNSTotal Voting Rights
19th Apr 20242:34 pmRNSDirector/PDMR Shareholding
18th Apr 202411:16 amRNSDirector/PDMR Shareholding
16th Apr 202412:35 pmRNSDirector/PDMR Shareholding
16th Apr 202412:33 pmRNSDirector/PDMR Shareholding
16th Apr 202412:32 pmRNSDirector/PDMR Shareholding
5th Apr 20247:00 amRNSResults of Scrip Dividend Alternative Election
8th Mar 20248:52 amRNSSale of H20 Shopping Centre Investment, Madrid
1st Mar 20247:00 amRNSTrading Update and Dividend Announcement
13th Feb 20245:03 pmRNSDirector/PDMR Shareholding
1st Feb 202411:58 amRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSTotal Voting Rights
31st Jan 202410:10 amRNSDirector/PDMR Shareholding
31st Jan 202410:10 amRNSDirector/PDMR Shareholding
31st Jan 202410:08 amRNSDirector/PDMR Shareholding
17th Jan 20247:00 amRNSResults of Scrip Dividend Alternative Election
15th Dec 20231:30 pmRNSHalf-year Report
6th Dec 20232:47 pmRNSDirector/PDMR Shareholding
27th Nov 20231:16 pmRNSDirector/PDMR Shareholding
24th Nov 20237:00 amRNSHalf-year Report
1st Nov 20237:00 amRNSTotal Voting Rights
31st Oct 20236:00 pmRNSDirector/PDMR Shareholding
31st Oct 20235:55 pmRNSDirector/PDMR Shareholding
31st Oct 20235:52 pmRNSDirector/PDMR Shareholding
25th Oct 20239:02 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.